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Rheumatoid arthritis is an inflammatory disease of unknown cause associated with
progressive joint damage and functional disability. Cunent therapy for rheumatoid
arthritis is toxic and is associated with a high incidence of side effects'
Recently, the inflammatory cytokine tumour necrosis factor o has been reported to be an
important, proximai mediator of rheumatoid arthritis. Antibodies or receptor antagonists
for this molecule have been shown to be effcctive therapy for rheumatoid arthritis.
However, such therapy remains expensive, inaccessible for the majority of patients and
associated with adverse effects.
The aim of this thesis was to explore alternate strategies that may alter inflammatory
cytokine production, particularly tumour necrosis factor u, and therefore provide a
possible treatment for rheumatoid arthritis. The focus of the alternate strategies as
described in this thesis are the eicosanoids, thromboxane A, and prostaglandin Er' These
strategies are safe, accessible and not associated with significant adverse events,
Alteration of these eicosanoids was shown to modulate tumour necrosis factor O-bothin
vitro and in vivo. The significance of this alteration of tumour necrosis factor cr by these




This work contains no material which has been accepted for the award of any degree or
diploma in any university or other tertiary institution and, to the best of my knowledge and
belief, contains no material previously published or written by another person, except
where due reference has been made in the text'
I give consent to this copy of my thesis, when deposited in the University Library, being






Associate Professor Michael J James, whose daily presence in the laboratory and ready
guidance when needed, combined with a respectful distance to allow freedom to
pursue different avenues as part of this thesis, was the ideal supervisor,
Associate Professor Leslie G Cleland, for his personal and clinical support while
working as a registr ar attachedwith his unit, his encouragement to pursue an academic
career and in his assistance with grant application. His contribution to reading and
marking of this thesis and publications was greatly appreciated, as \Mas the generous
spirit in which he performed these time-consuming chores,
MarieAnne Demasi, for her assistance with experiments and techniques in the
laboratory, especially in the f,rrst year and for utilising her diagram of coX- 1, Figure
Gillian Caughey, for her ready assistance with experiments, and especially for her
helpful advice when things went wrong. Her excellent thesis generated some of the
ideas for this current one and I greatly appreciated the freedom and generosity in
which she shared her findings,










Cindy Hall, for her assistance with making the rat chow and advice on animal
experiments,
Ashley Connolly, for using some of his ELISA techniques in measurement of rat
TNFo (Connolly 1998),
To the SA Blood bank for the provision of buffy coats, from which monocytes were
prepared,
To my brother in law and friend, Brad Cowain, for his assistance with computer
technology and formatting,
Finally and most importantly, to my wife, Taryn Cowain, my best friend, for her
acceptance and reassurance that enabled this thesis to be a positive and worthwhile
experience.
a
X1
